Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Dec 2025 for MiNK Therapeutics, Inc., €12k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Robert Peter Kadlec: trading record in brief
Robert Peter Kadlec appears in our data through filings on MiNK Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 1 December 2024 to 1 December 2025, the count stands at 5 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 3 December 2025, reports a share grant of €12k in MiNK Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert Peter Kadlec
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
1,218 shares@ US$11.0920.6% of flowCommon StockSEC:0001193125-25-306676:0
975 shares@ US$13.8620.6% of flowCommon StockSEC:0001193125-25-195091:0
1,883 shares@ US$7.1720.9% of flowCommon StockSEC:0000950170-25-081609:0
1,536 shares@ US$8.7922.9% of flowCommon StockSEC:0000950170-25-033540:0
12,286 shares@ US$0.7315.0% of flowCommon StockSEC:0000950170-24-134524:0
5 of 5 declarations
